BackSol-Gel Technologies Overview

Sol-Gel Technologies Common Stock

Latest common stock for SLGL: $1.4M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$1.39M
79.97% YoYΔ $619000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Sol-Gel Technologies Common Stock History

Loading

Sol-Gel Technologies vs. peers: Common Stock Comparison

Loading

Sol-Gel Technologies Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Sol-Gel Technologies (SLGL) FAQ

Sol-Gel Technologies (SLGL) currently reports a common stock of $1.4M as of June 2026. That compares with $770K in the prior-year period — up 80.0% year over year. Use the charts on this page to explore Sol-Gel Technologies's common stock history and peer comparisons.

Sol-Gel Technologies's common stock increased from $770K to $1.4M — a 80.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sol-Gel Technologies reported $1.4M in common stock as of June 2026. That compares with $770K in the prior-year period — up 80.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sol-Gel Technologies, and consider following SLGL for alerts when major investors trade the stock.

Sol-Gel Technologies is classified in the Healthcare sector. On common stock, it currently shows $1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLGL with unrelated industries.